These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20722436)

  • 1. Poly(L-lactide)-vitamin E TPGS nanoparticles enhanced the cytotoxicity of doxorubicin in drug-resistant MCF-7 breast cancer cells.
    Li PY; Lai PS; Hung WC; Syu WJ
    Biomacromolecules; 2010 Oct; 11(10):2576-82. PubMed ID: 20722436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced drug resistance suppression by serum-stable micelles from multi-arm amphiphilic block copolymers and tocopheryl polyethylene glycol 1000 succinate.
    He L; Jiang C; Ren J; Pan X; Qiu Z; Xia Y; Wang T; Guo J; Li J; Li W
    Nanomedicine (Lond); 2024; 19(14):1297-1311. PubMed ID: 39046514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TPGS nanoparticles co-loaded with ABT-737 and R848 for breast cancer therapy.
    Lang X; Wang X; Han M; Guo Y; Dong Z
    Biomed Pharmacother; 2024 Aug; 177():117107. PubMed ID: 38996708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, evaluation and metabolites study in rats of novel amentoflavone-loaded TPGS/soluplus mixed nanomicelles.
    Feng X; Chen Y; Li L; Zhang Y; Zhang L; Zhang Z
    Drug Deliv; 2020 Dec; 27(1):137-150. PubMed ID: 31913733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in the Application of Vitamin E TPGS for Drug Delivery.
    Yang C; Wu T; Qi Y; Zhang Z
    Theranostics; 2018; 8(2):464-485. PubMed ID: 29290821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Therapeutic Effect of Natural Killer Cells on Doxorubicin-Resistant Breast Cancer Cells In Vitro.
    Hwang MH; Li XJ; Kim JE; Jeong SY; Lee SW; Lee J; Ahn BC
    PLoS One; 2015; 10(8):e0136209. PubMed ID: 26295571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the Sensitivity of MCF-7 and MCF-7/DX Breast Cancer Cells to Cytostatic in the Presence of Metformin.
    Płonka-Czerw J; Żyrek L; Latocha M
    Molecules; 2024 Jul; 29(15):. PubMed ID: 39124936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The siRNAsome: A Cation-Free and Versatile Nanostructure for siRNA and Drug Co-delivery.
    Zheng M; Jiang T; Yang W; Zou Y; Wu H; Liu X; Zhu F; Qian R; Ling D; McDonald K; Shi J; Shi B
    Angew Chem Int Ed Engl; 2019 Apr; 58(15):4938-4942. PubMed ID: 30737876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Nok": a phytosterol-based amphiphile enabling transition-metal-catalyzed couplings in water at room temperature.
    Klumphu P; Lipshutz BH
    J Org Chem; 2014 Feb; 79(3):888-900. PubMed ID: 24447127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid Polymeric Nanoparticles of Albendazole: Synthesis, Physico-Chemical Characterization and Biological Activity.
    Racoviceanu R; Trandafirescu C; Voicu M; Ghiulai R; Borcan F; Dehelean C; Watz C; Aigner Z; Ambrus R; Coricovac DE; Cîrcioban D; Mioc A; Szuhanek CA; Şoica C
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33158183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations on agglomeration and haemocompatibility of vitamin E TPGS surface modified berberine chloride nanoparticles.
    Vuddanda PR; Rajamanickam VM; Yaspal M; Singh S
    Biomed Res Int; 2014; 2014():951942. PubMed ID: 25162037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TPGS-750-M: a second-generation amphiphile for metal-catalyzed cross-couplings in water at room temperature.
    Lipshutz BH; Ghorai S; Abela AR; Moser R; Nishikata T; Duplais C; Krasovskiy A; Gaston RD; Gadwood RC
    J Org Chem; 2011 Jun; 76(11):4379-91. PubMed ID: 21548658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified routes to the "designer" surfactant PQS.
    Moser R; Ghorai S; Lipshutz BH
    J Org Chem; 2012 Apr; 77(7):3143-8. PubMed ID: 22413960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro and In Vivo Effect of pH-Sensitive PLGA-TPGS-Based Hybrid Nanoparticles Loaded with Doxorubicin for Breast Cancer Therapy.
    Fernandes RS; Arribada RG; Silva JO; Silva-Cunha A; Townsend DM; Ferreira LAM; Barros ALB
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A GSH/CB Dual-Controlled Self-Assembled Nanomedicine for High-Efficacy Doxorubicin-Resistant Breast Cancer Therapy.
    Yang Y; Zhao Q; Peng Z; Zhou Y; Niu MM; Chen L
    Front Pharmacol; 2021; 12():811724. PubMed ID: 35095524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influencing factors and strategies of enhancing nanoparticles into tumors
    Zhang M; Gao S; Yang D; Fang Y; Lin X; Jin X; Liu Y; Liu X; Su K; Shi K
    Acta Pharm Sin B; 2021 Aug; 11(8):2265-2285. PubMed ID: 34522587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide-Targeted Lcn2 siRNA PEGylated Liposomes as a Treatment for Metastatic Breast Cancer.
    Gote V; Pal D
    Bioengineering (Basel); 2021 Apr; 8(4):. PubMed ID: 33916786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity.
    Ashrafizadeh M; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Bagherian M; Azami N; Bejandi AK; Hushmandi K; Ang HL; Makvandi P; Khan H; Kumar AP
    Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33187385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity.
    Pieper S; Onafuye H; Mulac D; Cinatl J; Wass MN; Michaelis M; Langer K
    Beilstein J Nanotechnol; 2019; 10():2062-2072. PubMed ID: 31728254
    [No Abstract]   [Full Text] [Related]  

  • 20. Curcumin Combination Chemotherapy: The Implication and Efficacy in Cancer.
    Tan BL; Norhaizan ME
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31295906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.